Dr. Daniel Von Hoff introduces us to his poster session at ASCO 2012. His poster focuses on finding new targets for pancreatic cancer patients to try to treat the cancer more effectively. This interview was filmed at the American Society of Clinical Oncology Annual Meeting in Chicago 2012. Daniel Von Hoff, MD, PhD is currently Physician in Chief and Director of Translational Research at TGen (Translational Genomics Research Institute) in Phoenix, Arizona. He is also Chief Scientific Officer for US Oncology and for Scottsdale Healthcare's Clinical Research Institute. He is also a Clinical Professor of Medicine, University of Arizona.
Views: 476 Vital Options International
Dr. Daniel Von Hoff addresses the audience at the 2017 15th Annual Seena Magowitz Golf Classic in Boston on the present state of pancreatic cancer including earlier detection and improved survival rates. An overview of past therapies, new therapies, and future therapies that will continue to increase pancreatic cancer survival rates that will one day lead to prevention and a cure. The presentation is about applying the best possible science against pancreatic cancer....ASAP. Dr. Von Hoff thanks the participating sponsors and donors of the Seena Magwitz Foundation that have funded clinical studies that have achieved significant results over the last 15 years. This is a very informative presentation lasting about 29 minutes and lays the foundation of the final assault on pancreatic cancer. Dr. Daniel Von Hoff is Physician -in-Chief at the Translational Genomics Research Institute (TGen); Virginia G. Piper Distinguished Chair for Innovative Cancer Research, HonorHealth Senior Consultant, Clinical Investigation, City of Hope. http://www.seenamagowitzfoundation.org/ https://www.facebook.com/Seena.Magowitz.Foundation https://www.tgen.org/ https://www.honorhealth.com/company/research-institute https://www.honorhealth.com/medical-services/cancer-care/clinical-trials
Views: 1437 Donovan's Steakhouse
Dr. Daniel Von Hoff, chief scientific officer at the Virginia G. Piper Cancer Center at Scottsdale Healthcare, was keynote speaker at a recent special edition Scottsdale Mayor and Council Breakfast. Dr. Von Hoff's presentation focused on the strides against cancer made at the Virginia G. Piper Cancer Center through its Phase I clinical trials and collaborations with TGen and other research partners. For more information about the Virginia G. Piper Cancer Center at Scottsdale Healthcare, visit http://www.shc.org/cancer. For information about specific clinical trials currently open at the Virginia G. Piper Cancer Center, call 1-877-273-3713 or email email@example.com. Learn more about Scottsdale Healthcare at http://www.shc.org. Follow us on Twitter at http://www.twitter.com/SHCpublicinfo and on Facebook at http://www.facebook.com/scottsdalehealthcare.
Views: 2445 ScottsdaleHealthcare
Pancreatic cancer clinical trials are underway at the Virginia G. Piper Cancer Center at Scottsdale Healthcare. The center is a primary clinical research site for the Stand Up to Cancer (SU2C) Dream Team pancreatic cancer research project. Daniel Von Hoff, MD, chief scientific officer at the Virginia G. Piper Cancer Center at Scottsdale Healthcare and physician-in-chief at the Translational Genomics Research Institute (TGen), is co-leader of the Stand Up to Cancer pancreatic cancer Dream Team. Ramesh Ramanathan, MD is the medical director at Virginia G. Piper Cancer Center Clinical Trials. "Cutting Off the Fuel Supply, A New Approach to the Treatment of Pancreatic Cancer" clinical trials include: • Using a drug to break through the tough coating surrounding the cancer so a second drug can kill the cancer cells. This combination is showing positive preliminary results in actually shrinking tumors. • Another effort is examining a tumor's molecular profile using state-of-the art molecular profiling techniques to personalize treatment for individual patients. Cancer patients travel from across Arizona, the United States and beyond for treatment at the Virginia G. Piper Cancer Center at Scottsdale Healthcare. The center opened in 2001 as the first major cancer center in greater Phoenix to offer comprehensive cancer research, diagnosis, treatment, prevention and support services in a single location. To learn about eligibility to participate in clinical trials at the Virginia G. Piper Cancer Center at Scottsdale Healthcare, contact the cancer care coordinator at 480-323-1339, toll free at 1-877-273-3713 or firstname.lastname@example.org. For more information about current studies, visit http://www.shc.org/clinicaltrials. Follow us on Twitter at http://www.twitter.com/SHCpublicinfo and on Facebook at http://www.facebook.com/scottsdalehealthcare.
Views: 446 ScottsdaleHealthcare
http://www.medpagetoday.com Daniel Von Hoff, M.D., of the Scottsdale Clinical Research Institute in Arizona SAN DIEGO, April 15 -- Eight of nine patients with metastatic basal cell carcinoma had durable clinical benefit with minimal toxicity when treated with an investigational compound that inhibits signaling in the Hedgehog pathway. Medpage Today: http://medpagetoday.com Online CME - Continuing medical education: http://www.medpagetoday.com/cme/ Latest medical news: http://www.medpagetoday.com/latest/ The MedPage Today app: iOS: https://goo.gl/JKrkHq Android: https://play.google.com/store/apps/details?id=com.medpagetoday.medpage MedPage Today Youtube Channel: https://www.youtube.com/user/MedPageToday Medpage Today on Facebook: https://www.facebook.com/MedPageToday
Views: 881 MedPage Today
Right now, about 50% of people diagnosed with cancer will be cured. And Daniel Von Hoff, MD and Chief Scientific Officer says that's the best kept secret about the disease. Learn more: https://www.honorhealth.com/medical-services/cancer-care. Featuring: Daniel Von Hoff, MD, Chief Scientific Officer, HonorHealth Research Institute in Scottsdale, AZ.
Views: 166 HonorHealth
The Virginia G. Piper Cancer Center at Scottsdale Healthcare is one of the original Stand Up to Cancer Dream Team sites, studying new cancer treatments for pancreatic cancer. Led by Dr. Daniel Von Hoff, the studies have shown encouraging results in improving quality of life and extending life expectancy for patients with advanced pancreatic cancer. Hear Dr. Von Hoff's NPR interview about the Dream Teams: http://www.kjzz.org/content/1303/valley-physician-part-dream-teams-fighting-cancer Virginia G. Piper Cancer Center Clinical Trials is a partnership between Scottsdale Healthcare and TGen that treats cancer patients with promising new drugs, and has built a national reputation for its drug development programs and treating advanced and rare cancers. Individuals seeking information about clinical trials at the Virginia G. Piper Cancer Center at Scottsdale Healthcare (http://www.shc.org/clinicaltrials) may call 480-323-1339; toll free at 1-877-273-3713 or via email email@example.com. Learn more about Scottsdale Healthcare at http://www.shc.org. Follow us on Twitter at http://www.twitter.com/SHCpublicinfo and on Facebook at http://www.facebook.com/scottsdalehealthcare.
Views: 541 ScottsdaleHealthcare
The war on cancer is really paying off now. The science and technology has gotten better to find targets--to find the tumor, to fine-tune therapies for the many different kinds of cancer affecting people. Learn more: https://www.honorhealth.com/medical-services/cancer-care. Featuring: Daniel Von Hoff, MD, Chief Scientific Officer, HonorHealth Research Institute in Scottsdale, AZ.
Views: 136 HonorHealth
In July of 2010 Dr. Randy Johns was given a "lethal" cancer diagnosis with a prognosis of two months to two years best-case-scenario. Opting to bypass conventional treatments he was able to not only survive aggressive metastatic cancer but THRIVE! Powerful story of hope and inspiration. http://Texarkana.ElevationHealth.com Late-stage Ulcerated Malignant Melanoma Cancer Thriver Dr. Randy Johns
Views: 962 Dr. Randy Johns
The Virginia G. Piper Cancer Center at Scottsdale Healthcare opened in 2001 as the first major cancer center in greater Phoenix to offer comprehensive cancer research, diagnosis, treatment and support services in a single location at Scottsdale Healthcare Shea Medical Center. Through our partnerships with community physicians, Scottsdale Healthcare Research Institute, the Translational Genomics Research Institute (TGen) and others, the patient and supportive care services you deserve have never been easier to access. Our Cancer Care Coordinators are experienced advanced practice nurses with expertise in oncology. From the time youre diagnosed, this nurse coordinator is available as a dedicated member of your cancer care team and will facilitate personalized cancer care for you and your family. Learn more at http://www.shc.org. Follow us on Twitter at http://www.twitter.com/SHCpublicinfo and on Facebook at http://www.facebook.com/scottsdalehealthcare. To contact a Cancer Care Coordinator, Call: 480-323-1255 (toll free 1-877- 273-3639) Email: firstname.lastname@example.org
Views: 606 ScottsdaleHealthcare
Scottsdale Healthcare is one of the Southwest's leading health systems, recognized for its medical innovations and superior personalized patient care. That same commitment to personalized care holds true for patients participating in clinical trials at the Scottsdale Healthcare Research Institute. Physicians and scientists at the Virginia G. Piper Cancer Center at Scottsdale Healthcare collaborate with leading research universities to provide a unique, personalized medicine approach through a strategic alliance with the Translational Genomics Research Institute (TGen), a world leader in developing smarter treatments for complex diseases. Scottsdale Healthcare is a primary clinical research site for TGen, providing patients with access to cutting edge technologies. Through this alliance, patients with cancer throughout Arizona and the world have the opportunity to participate in clinical trials of revolutionary cancer treatments at the Virginia G. Piper Cancer Center at Scottsdale Healthcare. Learn more at http://www.shc.org/clinicaltrials. For additional information about clinical trials available at Scottsdale Healthcare, call 480-323-1339 (toll free: 1-877-273-3713), or e-mail email@example.com. Follow us on Twitter at http://www.twitter.com/SHCpublicinfo and on Facebook at http://www.facebook.com/scottsdalehealthcare.
Views: 435 ScottsdaleHealthcare
Dick O'Neal, a pancreatic cancer survivor addresses the audience at the December 3, 2011 Seena Magowitz Foundation Golf Classic Luncheon in Phoenix, Arizona.
Views: 410 Donovan's Steakhouse
From North Carolina - People who experience a sudden drop in blood pressure when changing positions are at raised risk of heart failure, according to a report published in Hypertension. Researchers followed individuals for an avg. of 17.5 years, finding that people whose blood pressure dropped suddenly when moving from lying down to standing up had 1.5x increased risk of developing heart failure. From Seattle - Scientists have made a breakthrough in treating pancreatic cancer, according to a report published in Cancer Cell. Researchers combined gemcitabine with an enzyme known as PEGPH20 to treat a mouse model with pancreatic cancer. Results showed that the drug combo effectively broke through the tumours resistance and extended the rodent's survival by 70%. From Arizona - A new report published in Radiology finds that two MRI techniques can greatly improve detection of pulmonary embolism. Researchers found that adding the techniques VIBE and true FISP to MR pulmonary imaging significantly improved sensitivity and accuracy of pulmonary embolism detection.
Views: 39 insidermedicine
2009 Seena Magowitz Foundation Banquet and Casino Night, December 4, 5 2009 held at the Westin Kierland Resort in Scottsdale, Arizona. Video slide presentation compliments of Donovan's Steakhouse in Phoenix, Arizona as a public service. http://www.seenamagowitzfoundation.org/ http://www.donovanssteakhouse.com/phoenix-steakhouse.html
Views: 484 Donovan's Steakhouse